During the past decade, PMG Research of Knoxville conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 20 clinical trials were completed, i.e. on average, 117.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PMG Research of Knoxville" #1 sponsor was "Pfizer" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Flexion Therapeutics, Inc." with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PMG Research of Knoxville" #1 collaborator was "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Integrated Medical Development" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "PMG Research of Knoxville" are "Type 2 Diabetes Mellitus" (4 trials), "Osteoarthritis of the Knee" (3 trials), "Osteoarthritis, Knee" (3 trials), "Cardiovascular Disease" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "PMG Research of Knoxville" in a lesser frequency.

Most popular intervention types in "PMG Research of Knoxville" are "Drug" (20 trials), "Other" (4 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Dulaglutide" (3 trials), "FX006 32 mg" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "40 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "PMG Research of Knoxville" are 26 trials for "All" genders.

Currently, there are NaN active trials in "PMG Research of Knoxville". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in PMG Research of Knoxville, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in PMG Research of Knoxville, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".